Financials

  • Market Capitalization 8.92 M
  • Employee 8
  • Founded N/A
  • CEO N/A
  • Website www.aprea.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q6Q3K37
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.44
Price to sales ratio
19.52

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4811
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.25 USD-3.85%+4.17%-57.63%-51.47%10.26 M USD
4829
CRIS
Curis, Inc. - Common Stock
4.75 USD-4.23%-18.80%+979.55%+154.01%9.26 M USD
4845
BRTX
BioRestorative Therapies, Inc. - Common Stock
0.34 USD-2.86%-10.53%-5.56%-78.62%8.66 M USD
4851
QNRX
Quoin Pharmaceuticals Ltd - American Depositary Shares
4.23 USD-4.94%-7.24%-2.53%-54.61%8.50 M USD

Frequently asked questions about Aprea Therapeutics, Inc. - Common Stock

What is the Aprea Therapeutics, Inc. - Common Stock stock price today?

The current price of Aprea Therapeutics, Inc. - Common Stock (APRE) is 0.72. Over the past 24 hours, the stock has changed by -1.37%. Follow the APRE chart for real-time price dynamics.

What is the stock ticker of Aprea Therapeutics, Inc. - Common Stock?

Aprea Therapeutics, Inc. - Common Stock trades under the ticker APRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Aprea Therapeutics, Inc. - Common Stock stock going up?

APRE has changed by -4.00% over the last week, +4.35% over the last month, and -56.63% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Aprea Therapeutics, Inc. - Common Stock net income for the last quarter?

Aprea Therapeutics, Inc. - Common Stock reported net income of -3.29 M for the last quarter. The previous quarter showed -2.46 M, which means net income changed by -33.89%.

How many employees does Aprea Therapeutics, Inc. - Common Stock have?

As of the latest available data, Aprea Therapeutics, Inc. - Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

What is Aprea Therapeutics, Inc. - Common Stock EBITDA?

Aprea Therapeutics, Inc. - Common Stock EBITDA is -3.42 M, and its EBITDA margin is -44.32 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Aprea Therapeutics, Inc. - Common Stock stock?

You can buy Aprea Therapeutics, Inc. - Common Stock (APRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Aprea Therapeutics, Inc. - Common Stock stock?

Investing in Aprea Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the APRE chart and related analysis on metatrader.com as part of your research.

News